Zika Virus Infection and Effects on Human Neural Stem Cells, Neurospheres, and Brain Organoids
Source Garcez et al., 2016 · D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil · 10.1126/science.aad5252
Abstract
This protocol describes the infection of human iPSC-derived neural stem cells, neurospheres, and brain organoids with Zika virus (ZIKV) to investigate the effects of ZIKV infection during neurogenesis. The study demonstrates that ZIKV targets human brain cells, reduces their viability and growth, and induces cell death in neural stem cells, providing evidence of how ZIKV may impair human brain development during early fetal stages.
Protocol overview
21 steps across 6 phases
- 1 Culture human iPS-derived NSCs
- 2 Expose NSCs to Zika virus
- 3 Incubate infected NSCs for 24 hours
- 1 Culture mock- and ZIKV-infected NSCs as neurospheres
- 2 Assess neurosphere morphology at 3 days in vitro (DIV)
- 3 Count neurosphere numbers at 6 DIV
- 1 Perform immunocytochemistry for ZIKV detection
- 2 Quantify ZIKV-infected SOX2-positive cells
- 3 Detect ZIKV RNA by quantitative RT-PCR
- 1 Prepare neurospheres for electron microscopy
- 2 Image and characterize ultrastructure
- 1 Culture human iPS-derived brain organoids
- 2 Expose 35-day-old organoids to mock or ZIKV
- 3 Measure organoid area before and after 11 DIV of viral exposure
- 4 Document organoid morphology and cell detachment
- 1 Culture NSCs infected with Dengue virus 2 (DENV2)
- 2 Assess DENV2 infection rate at 24 hours
- 3 Measure caspase 3/7-mediated cell death at 3 DIV
- 4 Compare cell viability at 6 DIV
- 5 Assess DENV2-exposed neurosphere morphology at 6 DIV
- 6 Measure growth of DENV2-exposed brain organoids at 11 DIV
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Garcez et al., 2016. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol